Categories AlphaGraphs, Analysis, Retail

Q2 marks J.M.Smucker’s third consecutive quarterly results miss

In its third consecutive quarterly results miss, J. M. Smucker Company (SJM) Wednesday reported second-quarter earnings of $2.17 per share, which came below analysts’ expectation of $2.35 per share.

Net sales rose 5% to $2.02 billion, but it missed the Street consensus of $2.05 billion. Excluding the impact from Ainsworth acquisition, net sales declined 1% driven by lower net price realization on coffee, peanut butter, and pet food and pet snacks.

The disappointing results sent SJM shares tumbling 5.3% during pre-market trading.

JM Smucker second quarter 2019 Earnings Infographic

During the trailing two quarters, the food company had reported disappointing results, missing analysts’ expectations on both revenue and income. The poor results had weighed on the stock, which has been strictly trading sideways throughout this year. The stock is currently trading down 11% so far this year.

The saving grace during the second quarter was the company’s pet foods segment, which reported a sales increase of 32% riding on Ainsworth acquisition. All the other segments reported year-over-year sales declines.

The divestiture of its U.S. baking business in August partially weighed on the gross profit, which saw a modest 2% increase.

Burlington Stores’ stock soars 7% after Q3 results beat

Sending further signs of slow growth, the company lowered its 2019 full-year outlook for revenue and net income. It currently expects full-year revenue of about $7.9 billion, lower than the prior guidance of $8 billion.

Meanwhile, adjusted EPS guidance range for the same period was slashed from $8.40 – $8.65 to $8.00 – $8.20.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top